Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides

Mingjun Wang, Sheila T. Tang, Anette Stryhn, Sune Justesen, Mette V. Larsen, Morten H. Dziegiel, David Lewinsohn, Søren Buus, Ole Lund, Mogens H. Claesson

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Major histocompatibility complex (MHC) class I restricted cytotoxic T lymphocytes (CTL) are known to play an important role in the control of Mycobacterium tuberculosis infection so identification of CTL epitopes from M. tuberculosis is of importance for the development of effective peptide-based vaccines. In the present work, bioinformatics technology was employed to predict binding motifs of 9mer peptides derived from M. tuberculosis for the 12 HLA-I supertypes. Subsequently, the predicted peptides were synthesized and assayed for binding to HLA-I molecules in a biochemically based system. The antigenicity of a total of 157 peptides with measured affinity for HLA-I molecules of KD≤500nm were evaluated using peripheral blood T cells from strongly purified protein derivative reactive healthy donors. Of the 157 peptides, eight peptides (5%) were found to induce T-cell responses. As judged from blocking with HLA class I and II subtype antibodies in the ELISPOT assay culture, none of the eight antigenic peptides induced HLA class I restricted CD8+ T-cell responses. Instead all responses were blocked by pan-HLA class II and anti-HLA-DR antibodies. In addition, CD4+ T-cell depletion before the 10days of expansion, resulted in total loss of reactivity in the ELISPOT culture for most peptide specificities. FACS analyses with intracellular interferon-γ staining of T cells expanded in the presence of M. tuberculosis peptides confirmed that the responsive cells were indeed CD4+. In conclusion, T-cell immunity against HLA-I binding 9mer M. tuberculosis-derived peptides might in many cases turn out to be mediated by CD4+ T cells and restricted by HLA-II molecules. The use of 9mer peptides recognized by both CD8+ and CD4+ T cells might be of importance for the development of future M. tuberculosis peptide-based vaccines.

Original languageEnglish (US)
Pages (from-to)482-491
Number of pages10
JournalImmunology
Volume132
Issue number4
DOIs
StatePublished - Apr 2011

Fingerprint

Major Histocompatibility Complex
Mycobacterium tuberculosis
T-Lymphocytes
Peptides
Enzyme-Linked Immunospot Assay
Subunit Vaccines
Cytotoxic T-Lymphocytes
Tuberculosis Vaccines
Mycobacterium Infections
T-Lymphocyte Epitopes
Antibodies
HLA-DR Antigens
Mycobacterium
Computational Biology
Interferons
Immunity
Blood Cells
Tuberculosis
Staining and Labeling
Technology

Keywords

  • Cytotoxic T lymphocyte epitope
  • HLA-I
  • HLA-II
  • Mycobacterium tuberculosis
  • Vaccine

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Wang, M., Tang, S. T., Stryhn, A., Justesen, S., Larsen, M. V., Dziegiel, M. H., ... Claesson, M. H. (2011). Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides. Immunology, 132(4), 482-491. https://doi.org/10.1111/j.1365-2567.2010.03383.x

Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides. / Wang, Mingjun; Tang, Sheila T.; Stryhn, Anette; Justesen, Sune; Larsen, Mette V.; Dziegiel, Morten H.; Lewinsohn, David; Buus, Søren; Lund, Ole; Claesson, Mogens H.

In: Immunology, Vol. 132, No. 4, 04.2011, p. 482-491.

Research output: Contribution to journalArticle

Wang, M, Tang, ST, Stryhn, A, Justesen, S, Larsen, MV, Dziegiel, MH, Lewinsohn, D, Buus, S, Lund, O & Claesson, MH 2011, 'Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides', Immunology, vol. 132, no. 4, pp. 482-491. https://doi.org/10.1111/j.1365-2567.2010.03383.x
Wang, Mingjun ; Tang, Sheila T. ; Stryhn, Anette ; Justesen, Sune ; Larsen, Mette V. ; Dziegiel, Morten H. ; Lewinsohn, David ; Buus, Søren ; Lund, Ole ; Claesson, Mogens H. / Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides. In: Immunology. 2011 ; Vol. 132, No. 4. pp. 482-491.
@article{0ed92905d137484a95f7889768996c2d,
title = "Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides",
abstract = "Major histocompatibility complex (MHC) class I restricted cytotoxic T lymphocytes (CTL) are known to play an important role in the control of Mycobacterium tuberculosis infection so identification of CTL epitopes from M. tuberculosis is of importance for the development of effective peptide-based vaccines. In the present work, bioinformatics technology was employed to predict binding motifs of 9mer peptides derived from M. tuberculosis for the 12 HLA-I supertypes. Subsequently, the predicted peptides were synthesized and assayed for binding to HLA-I molecules in a biochemically based system. The antigenicity of a total of 157 peptides with measured affinity for HLA-I molecules of KD≤500nm were evaluated using peripheral blood T cells from strongly purified protein derivative reactive healthy donors. Of the 157 peptides, eight peptides (5{\%}) were found to induce T-cell responses. As judged from blocking with HLA class I and II subtype antibodies in the ELISPOT assay culture, none of the eight antigenic peptides induced HLA class I restricted CD8+ T-cell responses. Instead all responses were blocked by pan-HLA class II and anti-HLA-DR antibodies. In addition, CD4+ T-cell depletion before the 10days of expansion, resulted in total loss of reactivity in the ELISPOT culture for most peptide specificities. FACS analyses with intracellular interferon-γ staining of T cells expanded in the presence of M. tuberculosis peptides confirmed that the responsive cells were indeed CD4+. In conclusion, T-cell immunity against HLA-I binding 9mer M. tuberculosis-derived peptides might in many cases turn out to be mediated by CD4+ T cells and restricted by HLA-II molecules. The use of 9mer peptides recognized by both CD8+ and CD4+ T cells might be of importance for the development of future M. tuberculosis peptide-based vaccines.",
keywords = "Cytotoxic T lymphocyte epitope, HLA-I, HLA-II, Mycobacterium tuberculosis, Vaccine",
author = "Mingjun Wang and Tang, {Sheila T.} and Anette Stryhn and Sune Justesen and Larsen, {Mette V.} and Dziegiel, {Morten H.} and David Lewinsohn and S{\o}ren Buus and Ole Lund and Claesson, {Mogens H.}",
year = "2011",
month = "4",
doi = "10.1111/j.1365-2567.2010.03383.x",
language = "English (US)",
volume = "132",
pages = "482--491",
journal = "Immunology",
issn = "0019-2805",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides

AU - Wang, Mingjun

AU - Tang, Sheila T.

AU - Stryhn, Anette

AU - Justesen, Sune

AU - Larsen, Mette V.

AU - Dziegiel, Morten H.

AU - Lewinsohn, David

AU - Buus, Søren

AU - Lund, Ole

AU - Claesson, Mogens H.

PY - 2011/4

Y1 - 2011/4

N2 - Major histocompatibility complex (MHC) class I restricted cytotoxic T lymphocytes (CTL) are known to play an important role in the control of Mycobacterium tuberculosis infection so identification of CTL epitopes from M. tuberculosis is of importance for the development of effective peptide-based vaccines. In the present work, bioinformatics technology was employed to predict binding motifs of 9mer peptides derived from M. tuberculosis for the 12 HLA-I supertypes. Subsequently, the predicted peptides were synthesized and assayed for binding to HLA-I molecules in a biochemically based system. The antigenicity of a total of 157 peptides with measured affinity for HLA-I molecules of KD≤500nm were evaluated using peripheral blood T cells from strongly purified protein derivative reactive healthy donors. Of the 157 peptides, eight peptides (5%) were found to induce T-cell responses. As judged from blocking with HLA class I and II subtype antibodies in the ELISPOT assay culture, none of the eight antigenic peptides induced HLA class I restricted CD8+ T-cell responses. Instead all responses were blocked by pan-HLA class II and anti-HLA-DR antibodies. In addition, CD4+ T-cell depletion before the 10days of expansion, resulted in total loss of reactivity in the ELISPOT culture for most peptide specificities. FACS analyses with intracellular interferon-γ staining of T cells expanded in the presence of M. tuberculosis peptides confirmed that the responsive cells were indeed CD4+. In conclusion, T-cell immunity against HLA-I binding 9mer M. tuberculosis-derived peptides might in many cases turn out to be mediated by CD4+ T cells and restricted by HLA-II molecules. The use of 9mer peptides recognized by both CD8+ and CD4+ T cells might be of importance for the development of future M. tuberculosis peptide-based vaccines.

AB - Major histocompatibility complex (MHC) class I restricted cytotoxic T lymphocytes (CTL) are known to play an important role in the control of Mycobacterium tuberculosis infection so identification of CTL epitopes from M. tuberculosis is of importance for the development of effective peptide-based vaccines. In the present work, bioinformatics technology was employed to predict binding motifs of 9mer peptides derived from M. tuberculosis for the 12 HLA-I supertypes. Subsequently, the predicted peptides were synthesized and assayed for binding to HLA-I molecules in a biochemically based system. The antigenicity of a total of 157 peptides with measured affinity for HLA-I molecules of KD≤500nm were evaluated using peripheral blood T cells from strongly purified protein derivative reactive healthy donors. Of the 157 peptides, eight peptides (5%) were found to induce T-cell responses. As judged from blocking with HLA class I and II subtype antibodies in the ELISPOT assay culture, none of the eight antigenic peptides induced HLA class I restricted CD8+ T-cell responses. Instead all responses were blocked by pan-HLA class II and anti-HLA-DR antibodies. In addition, CD4+ T-cell depletion before the 10days of expansion, resulted in total loss of reactivity in the ELISPOT culture for most peptide specificities. FACS analyses with intracellular interferon-γ staining of T cells expanded in the presence of M. tuberculosis peptides confirmed that the responsive cells were indeed CD4+. In conclusion, T-cell immunity against HLA-I binding 9mer M. tuberculosis-derived peptides might in many cases turn out to be mediated by CD4+ T cells and restricted by HLA-II molecules. The use of 9mer peptides recognized by both CD8+ and CD4+ T cells might be of importance for the development of future M. tuberculosis peptide-based vaccines.

KW - Cytotoxic T lymphocyte epitope

KW - HLA-I

KW - HLA-II

KW - Mycobacterium tuberculosis

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=79952498466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952498466&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2567.2010.03383.x

DO - 10.1111/j.1365-2567.2010.03383.x

M3 - Article

C2 - 21294723

AN - SCOPUS:79952498466

VL - 132

SP - 482

EP - 491

JO - Immunology

JF - Immunology

SN - 0019-2805

IS - 4

ER -